Showing results (201-210 of 500) with videos related to

Sort By:
Pageof 50
Proceedings of the National Academy of Sciences of the United States of America|March 29, 2007
Adaptive TGF-beta-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatmentSylvaine You, Bertrand Leforban, Corinne Garcia, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1986
Serologic and T cell recognition of truncated transplantation antigens encoded by in vitro deleted class I major histocompatibility genesJ McCluskey, J A Bluestone, J E Coligan, et al.
The Journal of Experimental Medicine|November 1, 1981
Anti-idiotypes to monoclonal anti-H-2 antibodies. II. Expression of anti-H-2Kk idiotypes on antibodies induced by anti-idiotype or H-2Kk antigenJ A Bluestone, S L Epstein, K Ozato, et al.
Frontiers in Medicine|January 12, 2019
Cytokines, Chemokines, and Other Biomarkers of Response for Checkpoint Inhibitor Therapy in Skin CancerJennifer A Bridge, James C Lee, Adil Daud, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1997
CD28/B7 costimulation regulates autoimmune diabetes induced with multiple low doses of streptozotocinK C Herold, V Vezys, A Koons, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 7, 1999
Lymphoproliferative disorder in CTLA-4 knockout mice is characterized by CD28-regulated activation of Th2 responsesR Khattri, J A Auger, M D Griffin, et al.
Science Translational Medicine|April 8, 2010
Ten years of the Immune Tolerance Network: an integrated clinical research organizationJeffrey A Bluestone, Alan M Krensky, Laurence A Turka, et al.
Nature Medicine|August 26, 2003
TGF-beta-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetesMériam Belghith, Jeffrey A Bluestone, Samia Barriot, et al.
Pageof 50